Steris to invest $600 million in North Carolina chemicals hub

STERIS plc said it will invest $600 million to build a formulated chemistries manufacturing and distribution center of excellence in Sanford, a project expected to create 335 jobs in Lee County. The move gives North Carolina another large industrial win and adds a healthcare-linked chemicals site to the state’s growing manufacturing map.

The company, known for sterilization and infection-prevention products used in hospitals and other medical settings, is expanding into a part of the supply chain that matters well beyond one factory floor. Formulated chemistries support hospital supplies, device sterilization and other medical applications that depend on tightly controlled production processes, making the Sanford site relevant to domestic production of strategically important materials.

State and local officials identified Sanford as the location, and the North Carolina governor’s office announced the project on Aug. 5 as a “center of excellence” for a leading health care company. Business North Carolina said the investment would add 335 jobs in Sanford, while WRAL reported that state and local officials had approved performance-based incentive packages potentially worth millions of dollars.

The scale of the commitment also reflects why North Carolina has become attractive to manufacturers looking to place capital in the Southeast. Reuters said the investment continues a broader pattern of advanced manufacturing projects moving into the region because of land availability, logistics access, workforce development incentives and proximity to major transport routes. Sanford’s position in central North Carolina gives STERIS access to those advantages while anchoring more industrial activity in Lee County.

For North Carolina, the immediate payoff will come in phases. A project of this size typically begins with construction jobs, then shifts to a permanent workforce once operations are running. The 335 projected positions should create demand for technicians, operators and logistics staff, while the distribution component raises the importance of transportation links and reliable infrastructure around the site.

The announcement also fits a larger push by healthcare and industrial companies to build more resilient supply chains after pandemic-era shortages exposed the risks of depending too heavily on overseas production. By placing a formulated chemistries hub in Sanford, STERIS is deepening its U.S. footprint and reducing exposure to long international supply lines for materials tied to healthcare delivery.

Large-scale spending like this usually signals confidence in durable demand. STERIS would not commit $600 million to a new North Carolina hub unless it saw room to expand domestic production for products that hospitals and medical-device customers need on a steady basis.